Back to Search

A Phase II Study Evaluating the Efficacy of Mosunetuzumab in Combination With Polatuzumab Vedotin in Untreated Follicular Lymphoma


  • Protocol Number: 202207147
  • Principal Investigator: Bartlett, Nancy
  • Cancer Types: Lymphoma

For more information on this trial, contact us here:

Phone
800-600-3606
Email
info@ccadmin.wustl.edu

Brief Summary

Protocol Interventions